Syncom Formulations (India) Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
- August 11, 2026
- Posted by: Kunal Singla
- Category: News
CMP Rs 14.34. Target 2027: Rs 17.00 (+21%). Target 2028: Rs 19.00 (+40%). Target 2030: Rs 26.00 (+88%).
Syncom Formulations (India) at Rs 14.34 is a diversified company whose share price target of Rs 17.00 for 2027 represents approximately 21 percent upside from the current market price. The Syncom Formulations (India) share price target rises to Rs 19.00 by 2028 and Rs 26.00 by 2030, implying a 4-year upside of approximately 88 percent from August 2026 levels. Valued at roughly 18x FY26 EPS (₹0.8), with earnings expected to compound near 15% annually before slowing to approximately12%..
The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the Syncom Formulations (India) share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.
Click Here – Get Free Investment Predictions
Syncom Formulations (India) Company Overview
| Metric | Details |
|---|---|
| NSE Ticker | SYNCOMF |
| Sector | Diversified |
| CMP (10 Aug 2026) | Rs 14.34 |
| Market Cap | Rs 1310 Cr |
| Syncom Formulations (India) Share Price Target 2027 | Rs 17.00 (+21%) |
| Syncom Formulations (India) Share Price Target 2028 | Rs 19.00 (+40%) |
| Syncom Formulations (India) Share Price Target 2030 | Rs 26.00 (+88%) |
| Bull Case 2030 | Rs 33 |
| Bear Case 2030 | Rs 20 |
What most investors miss: Operates in 15+ countries with 400+ registered products despite tiny EPS (Rs0.81) , high share count / low face-value stock, not a small operation
Valued at roughly 18x FY26 EPS (₹0. 8), with earnings expected to compound near 15% annually before slowing to approximately12%. The share price target of Rs 17.00 for 2027 and Rs 26.00 for 2030 reflect this earnings trajectory.
Why Is the Syncom Formulations (India) Share Price Target Set at Rs 17.00 for 2027
Core Business Revenue Growth and Market Position
This is the primary driver of the Syncom Formulations (India) share price target for 2027 and 2030. Valued at roughly 18x FY26 EPS (₹0.8), with earnings expected to compound near 15% annually before slowing to approximately12%.. Investors tracking this metric quarterly will have the earliest signal of whether the Syncom Formulations (India) share price target timeline is on track.
Margin Improvement and Operational Efficiency
The Syncom Formulations (India) share price target of Rs 17.00 for 2027, rising to Rs 26.00 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the Syncom Formulations (India) share price target thesis.
Balance Sheet Quality and Cash Flow Generation
This structural factor underpins the long-term Syncom Formulations (India) share price target of Rs 26.00 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.
Management Track Record and Strategic Execution
For the Syncom Formulations (India) share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 19.00 target in 2028 when earnings quality is most clearly visible.
India’s Economy Growth Creates Sector-Wide Tailwind for Syncom Formulations (India)
India’s long-term economic growth trajectory creates a secular tailwind for Syncom Formulations (India)’s business that amplifies the company-specific earnings compounding embedded in the Syncom Formulations (India) share price target 2030 of Rs 26.00 (+88% from CMP Rs 14.34).
Syncom Formulations (India) Share Price Targets 2027, 2028 and 2030
Syncom Formulations (India) Share Price Target 2027: Rs 17.00
The Syncom Formulations (India) share price target 2027 is Rs 17.00, representing approximately 21 percent upside from CMP Rs 14.34. Valued at roughly 18x FY26 EPS (₹0.8), with earnings expected to compound near 15% annually before slowing to approximately12%.. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the Syncom Formulations (India) share price target.
Syncom Formulations (India) Share Price Target 2028: Rs 19.00
The Syncom Formulations (India) share price target 2028 is Rs 19.00, implying approximately 40 percent upside from CMP. By FY29, Syncom Formulations (India) should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the Syncom Formulations (India) share price target thesis typically triggers institutional re-rating toward the Rs 19.00 level.
Syncom Formulations (India) Share Price Target 2030: Rs 26.00
The Syncom Formulations (India) share price target 2030 is Rs 26.00, implying approximately 88 percent upside from CMP and a 4-year CAGR of approximately 16 percent. By FY31, Syncom Formulations (India) should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.
Bull Case and Bear Case for Syncom Formulations (India) Share Price Target 2030
Bull Case: Rs 33
The bull case Syncom Formulations (India) share price target of Rs 33 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.
Bear Case: Rs 20
The bear case Syncom Formulations (India) share price target of Rs 20 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.
| Scenario | Target 2030 | Return |
|---|---|---|
| Bull Case | Rs 33 | +130% |
| Base Case | Rs 26.00 | +88% |
| Bear Case | Rs 20 | +39% |
Key Risks to the Syncom Formulations (India) Share Price Target
Earnings Growth Deceleration
Any slowdown in Syncom Formulations (India)’s core earnings growth below the projected rate would trigger a PE de-rating and delay the Syncom Formulations (India) share price target timeline.
Macro and Sector Headwinds
Global or Indian economic slowdown, regulatory changes, or commodity price cycles could negatively impact Syncom Formulations (India)’s revenues and the Syncom Formulations (India) share price target.
Competition and Market Share Pressure
Competitive intensity from existing players or new entrants could force Syncom Formulations (India) to reduce prices or increase spending, compressing the Syncom Formulations (India) share price target margins.
Premium Valuation Risk
If the current PE multiple is not supported by sustained earnings delivery, a de-rating could set back the Syncom Formulations (India) share price target timeline materially.
How to Invest in Syncom Formulations (India)
Use the Univest Screener to track Syncom Formulations (India)’s quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker SYNCOMF. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the Syncom Formulations (India) share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.
Use the Univest Screener to Track This Stock Live
Conclusion
The Syncom Formulations (India) share price target of Rs 17.00 for 2027, Rs 19.00 for 2028, and Rs 26.00 for 2030 reflects analyst consensus earnings compounding in the diversified sector. The 4-year upside of approximately 88 percent from CMP Rs 14.34 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Download the Univest iOS App or Univest Android App to track Syncom Formulations (India) share price live and get daily stock recommendations.
Frequently Asked Questions on Syncom Formulations (India) Share Price Target 2027 2028 and 2030
What is the Syncom Formulations (India) share price target for 2027?
Ans. The Syncom Formulations (India) share price target for 2027 is Rs 17.00, representing approximately 21 percent upside from CMP Rs 14.34 as of August 2026. Please verify all data at NSE India before investing.
What is the Syncom Formulations (India) share price target for 2030?
Ans. The Syncom Formulations (India) share price target for 2030 is Rs 26.00, implying approximately 88 percent upside from CMP Rs 14.34. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.
What is the Syncom Formulations (India) share price target for 2028?
Ans. The Syncom Formulations (India) share price target for 2028 is Rs 19.00, implying approximately 40 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.
Is Syncom Formulations (India) a good long-term investment?
Ans. Syncom Formulations (India) has a defined analyst projection for earnings compounding through FY31 in the diversified sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.
What are the key risks to the Syncom Formulations (India) share price target?
Ans. Key risks include sector-specific headwinds such as earnings growth deceleration, macro and sector headwinds, and broader macro slowdowns. Please review the full risks section in this article before investing.
What is the bull case for Syncom Formulations (India) share price by 2030?
Ans. The bull case Syncom Formulations (India) share price target for 2030 is Rs 33, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.
What is Syncom Formulations (India)’s current market cap?
Ans. Syncom Formulations (India) has a market cap of approximately Rs 1310 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.
How can I invest in Syncom Formulations (India)?
Ans. You can buy Syncom Formulations (India) shares through any SEBI-registered broker by searching for NSE ticker SYNCOMF. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.
